Brief: In8bio Announces Positive Update In Phase1 Trial Of Inb-100 In Leukemia
11/12/2023 22:00
Dec 11 (Reuters) - IN8BIO, Inc. INAB.O :
* IN8BIO ANNOUNCES POSITIVE CLINICAL UPDATE DEMONSTRATING
CONTINUED DURABLE COMPLETE REMISSION IN 100% OF EVALUABLE
PATIENTS IN PHASE 1 TRIAL OF INB-100 IN LEUKEMIA
Source text for Eikon: ID:nGNXX562p
Further company coverage: INAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IN8bio
See all newsIN8bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Biopharma firm IN8bio's Q2 net loss narrows as expenses decline
IN8bio Inc expected to post a loss of 37 cents a share - Earnings Preview
Brief: IN8BIO - Enters Capital On Demand Sales Agreement With Jonestrading For ATM Offering
IN8bio Q1 net loss narrows as R&D expenses fall